Advertisement
U.S. Markets closed

Suven Life Sciences Limited (SUVEN.BO)

BSE - BSE Real Time Price. Currency in INR
114.50-9.15 (-7.40%)
At close: 03:41PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 26.96B
Enterprise Value 26.06B
Trailing P/E 200.68
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)302.35
Price/Book (mrq)9.99
Enterprise Value/Revenue 292.79
Enterprise Value/EBITDA -11.71

Trading Information

Stock Price History

Beta (5Y Monthly) 1.58
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3169.00
52 Week Low 360.96
50-Day Moving Average 3143.72
200-Day Moving Average 3117.99

Share Statistics

Avg Vol (3 month) 350.93k
Avg Vol (10 day) 316.72k
Shares Outstanding 5218.07M
Implied Shares Outstanding 6N/A
Float 858.94M
% Held by Insiders 171.76%
% Held by Institutions 13.52%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 40.66
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Feb 14, 2019
Last Split Factor 22:1
Last Split Date 3Mar 23, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,183.39%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)89.02M
Revenue Per Share (ttm)0.41
Quarterly Revenue Growth (yoy)-73.50%
Gross Profit (ttm)N/A
EBITDA -1.31B
Net Income Avi to Common (ttm)-1.09B
Diluted EPS (ttm)-5.01
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.4B
Total Cash Per Share (mrq)11
Total Debt (mrq)7.1M
Total Debt/Equity (mrq)0.26
Current Ratio (mrq)N/A
Book Value Per Share (mrq)12.38

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A